ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2603

A Human Lupus Gut Pathobiont Accelerates Systemic Inflammation, Autoantibody Production and T Cell Dysregulation

Gregg Silverman1 and Laurence Morel2, 1NYU Grossman School of Medicine, New York, NY, 2Joe R. & Teresa Lozano Long School of Medicine, San Antonio, TX

Meeting: ACR Convergence 2024

Keywords: Animal Model, autoimmune diseases, microbiome, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: SLE – Etiology & Pathogenesis

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: The mechanisms by which the gut microbiome contributes to autoimmune pathogenesis remain poorly understood. In lupus patients, more than ten-fold blooms of Ruminococcus gnavus (RG) occur during nephritis flares. We, therefore, sought to identify mechanisms promoting the gut expansion of this pathobiont and its contribution to autoimmune pathogenesis.

Methods: With cellular and serologic assays, we evaluated the effects of RG gut colonization in lupus-prone B6.Sle1.Sle2.Sle3 (TC) mice. Fecal microbiota transfers (FMT) from active and inactive TC mice, vs controls were assessed in recipient mice, along with the influence of dietary tryptophan. The growth and metabolome of RG strains were evaluated in response to tryptophan, and for the direct in vitro effects of RG on Treg cells.

Results: After gavage, TC mice exhibited persistent colonization with only the lipoglycan (LG)-producing RG strain, which led to increased intestinal permeability and raised serum inflammatory cytokines, autoantibodies and T-cell activation. Conversely, after RG depletion Treg representation increased and inflammation subsided. Co-cultures of dendritic cells with LG-producing RG-induced Treg apoptosis. Whereas microbiota communities in TC mice naturally include RG and dietary tryptophan caused further RG expansion. Tryptophan metabolism also differed between the two strains tested. In standard medium, the lupus-associated RG strain produced less tryptamine, and less indole-3-acetaldehyde (IAAld) that in health acts through the Aryl hydrocarbon receptor (AhR) to improve intestinal barrier function. These observations suggest that the lupus-associated RG strain possesses a differential tryptophan catabolic pathway that correlates with pathogenic potential. Together, RG induced intestinal inflammation and systemic autoimmunity which was further accelerated by a high tryptophan diet.

Conclusion: Colonization with an LG-producing RG strain, akin to strains expanded in lupus patients in flare, directly contributes to Treg reduction and immune activation that drive autoimmunity. Hence, host genetics and tryptophan metabolism promote RG growth and immunoregulatory metabolite production. We therefore propose that targeted RG depletion may improve lupus outcomes.

Supporting image 1

Figure 1. R. gnavus strain 2 (Rg2) monocolonization induced autoimmune activation in Triple Congenic mice. (A) Experimental design. (B) Rg levels in control and Rg mono-colonized TC mice post 1 month inoculation. Immune phenotypes were analyzed 5 months after colonization. (C) Serum anti-dsDNA IgG. Frequency of splenic CD69+ CD4+ T cells (D), naïve CD4+ T cells (E), effector memory CD4+ T cells (F), IFN-γ+ CD4+ T cells (G), IL_10-producing non-Treg T cells (H), and germinal center B cells (I). (J) Serum anti-Rg lipoglycan IgG. (K) Correlation between serum anti-lipoglycan IgG and anti-dsDNA IgG. Mean + SEM compared with t tests. *: P < 0.05; **: P < 0.01.


Disclosures: G. Silverman: NYU, 10; L. Morel: None.

To cite this abstract in AMA style:

Silverman G, Morel L. A Human Lupus Gut Pathobiont Accelerates Systemic Inflammation, Autoantibody Production and T Cell Dysregulation [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/a-human-lupus-gut-pathobiont-accelerates-systemic-inflammation-autoantibody-production-and-t-cell-dysregulation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-human-lupus-gut-pathobiont-accelerates-systemic-inflammation-autoantibody-production-and-t-cell-dysregulation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology